Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents
: The Acute Catheterization and Urgent Intervention Triage Strategy trial.
Herzog, "Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents
in the United States," Circulation, vol.
If a repeat procedure is needed due to stent restenosis (which occurs more frequently with bare metal stents
), it carries a small risk of a heart attack or even death, says Dr.
"We have not yet identified any subsets of patients who don't benefit from receiving drug-eluting stents [by having less restenosis] compared with bare metal stents
," said David J.
Bare metal stents
, made of durable materials such as stainless steel and cobalt chromium, had better results.
As assessed by intravenous ultrasound, the percentage in-stent net volume obstruction at 6 months was 7.85% for the slow-release paclitaxel-eluting stent and 23.17% for the bare metal stent
, a 66% difference.
We believe this bare metal stent
system illustrates exceptional characteristics that will position it well in the approximately $1 billion international bare metal stent
market and as a platform for our very promising passive and drug-eluting coating systems that are currently in development."
CYPHER(R) Stent patients had lower rates of re-blockage, lower rates of re-treatment and less arterial narrowing than patients receiving a bare metal stent
. They also experienced a lower incidence of heart attacks and no increase in blood clots.
The Svelte IDS utilises a bare metal stent
platform, which received CE Mark certification in August of 2010 and is commercially available in select European and Latin American markets.
11 January 2010 - US-based Svelte Medical Systems Inc said on Friday it has started the European clinical trial of its "Stent-on-a-Wire" (SOAW) cobalt-chromium Bare Metal Stent
at the Thoraxcenter Research Center, Rotterdam, the Netherlands.
0.74, P < 0.001) in the biolimus A9 stent group as compared with the bare metal stent